360DX Media Bias

AI Generated News Bias (?): The provided source, 360Dx, leans towards a neutral perspective with regards to political or ideological biases.

The news snippets revolve around scientific and medical advancements, corporate developments, legal issues tied to the sector, and diagnostic innovations.

There is evidence of a focus on purposeful reporting of the details of each case without apparent endorsement or criticism of entities involved, like in the coverage of patent conflicts [360DX] [360DX] [360DX], regulatory actions [360DX] [360DX], commercial arrangements [360DX] [360DX] [360DX], and litigation proceedings [360DX].

Despite an absence of explicit agenda or bias, there's indirect commercial bias emanating from the consistent focus on companies' deals, partnerships, acquisitions, and innovations [360DX] [360DX] [360DX] [360DX] [360DX] [360DX].

Such information might interest potential investors or industry stakeholders more than the general public.

AI Bias: Helium AI was trained on vast, diverse data, including news sources of various biases.

This may inadvertently favor mainstream narratives or established scientific facts.

Nonetheless, Helium AI's design emphasizes neutrality over personal beliefs or biases.


August 30, 2023


Show Historical Bias


         


Customize Your AI News Feed. No Censorship. No Ads.




PrescriptiveSensationalImmatureCovering ResponsesAppeal to AuthorityOversimplificationPoliticalBegging The QuestionCircular ReasoningVictimizationGossipSubjectiveFearfulOpinionated12345678910

360DX Social Media Impact (?): 0



360DX Most Prescriptive Articles    

Top Five Articles on 360Dx Last Week: Foundation Medicine CDx FDA Approval; FDA Clearances; More

District Court Issues Injunction Prohibiting False Advertising in Natera-CareDx Legal Row

Top Five Articles on 360Dx Last Week: ADLM Taking on LDTs; Juno Dx Shuts Down; and More

Top Five Articles on 360Dx Last Week: Patients as Stakeholders; Survival of Labs; and More

Top Five Articles on 360Dx Last Week: Veracyte Q2 Results; Egoo Prepares for US Entry; and More

Amoy Diagnostics, AstraZeneca Partner to Advance PARP Inhibitor CDx For Maintenance Indication

Natera Sues NeoGenomics for Patent Infringement

USPTO Rejects Magnolia Medical Patent Claims Against Kurin

360DX Publishes More About


prostate cancer

360DX Most Similar Sources (?)


Genome Web

biospace.com

Endpoints

healio.com

STAT

fiercebiotech.com



2023-06-162023-07-042023-07-232023-08-112023-08-30360DX # Articles1510Average News Sentiment010360DX # ArticlesAverage News Sentiment



Click points to explore news by date. News sentiment ranges from -10 (very negative) to +10 (very positive) where 0 is neutral.





360DX Recent Articles

😊 DoMore Diagnostics, Proscia Ink Collaboration on Colorectal Cancer Histopathology Testing

business

The digital pathology firms will combine their technologies to help pathologists predict patient outcomes and incorporate AI-supported decision-making.

360DX     Aug 30, 2023

IdentifySensors Biologics, East West Manufacturing Partner on Rapid Saliva-Based Biosensor MDx

business

The firm's rapid technology uses saliva samples and graphene-based inks printed onto solid-state electronics to differentiate infectious diseases.

360DX     Aug 29, 2023

Oncocyte VitaGraft Kidney Transplant Test Receives CMS Coverage

Palmetto issued a positive coverage decision for VitaGraft Kidney under the same LCD covering CareDx's HeartCare transplant surveillance service.

360DX     Aug 29, 2023

Day Zero Diagnostics Wins $300K SBIR Grant for Fecal Microbiota Transplant Assay

The Boston firm will develop a sequencing-based safety and efficacy assay for fecal microbiota transplants called epiXact FMT.

360DX     Aug 29, 2023

As Labs Add CPT Codes for Digital Pathology Slides, Some Payors Balk at Reimbursements

business

Pathology laboratories have begun implementing CPT codes related to digitization of glass slides, and payors are signaling such charges may not be covered.

360DX     Aug 29, 2023

William Blair Initiates Coverage of Bio-Techne With Outperform Rating

business

The investment bank emphasized Bio-Techne's position in multiple high-growth and attractive end markets, including cell and gene therapy, spatial biology, and liquid biopsy.

360DX     Aug 29, 2023

Researchers Find Cardiovascular Marker Linked to Overall Mortality ... - 360Dx

NEW YORK – Researchers from Quest Diagnostics and collaborators have found that changes in levels of the cardiovascular risk marker free myeloperoxidase (MPO) appear correlated with an individual's overall mortality risk.

360DX     Aug 28, 2023

Bionano Genomics' Chinese OEM Partner Nabs NMPA Approval for Sample Prep Products

tech

Through its OEM partner A-smart MedTech, Bionano can now sell two more sample prep products for IVD applications in reproductive health in China.

360DX     Aug 28, 2023

Michigan Pain Center Owner Pays $6.5M to Settle Lab Fraud Claims

The US Department of Justice alleged that Rajendra Bothra billed the government for unnecessary urine testing along with other unnecessary medical services.

360DX     Aug 28, 2023

Danaher to Acquire Abcam for $5.7B

business

Cambridge, UK-based Abcam provides antibodies, reagents, biomarkers, and assays for drug discovery, life sciences research, and diagnostics.

360DX     Aug 28, 2023

Top Five Articles on 360Dx Last Week: Prison for Lab Owner; Grail's Cancer Detection Deal; More

business

Last week, readers were most interested in a 27-year prison term handed down for a $463 million scheme to defraud Medicare.

360DX     Aug 28, 2023

Singapore's Mirxes Inks Agreements for Cancer Early Detection Tests in China, Indonesia

Mirxes signed an MOU to scale up manufacturing of its tests in China and expanded an existing commercialization partnership in Indonesia.

360DX     Aug 25, 2023